PERSPECTA

News from every angle

← Back to headlines

Evercore ISI Sees Long-Term Growth Potential For BioCryst Pharmaceuticals, Inc. (BCRX) Following Astria Acquisition

Evercore ISI projects long-term growth potential for BioCryst Pharmaceuticals, Inc. (BCRX) following its acquisition of Astria.

23 Feb, 21:42 — 23 Feb, 21:42
PostShare

Sources

Showing 1 of 1 sources
YahooMostly Factual184d ago

Evercore ISI Sees Long-Term Growth Potential For BioCryst Pharmaceuticals, Inc. (BCRX) Following Astria Acquisition

Read full article →

Related Stories

Charles Schwab Expands Crypto Platform With Three New Digital Assets

19m ago

Cathie Wood’s ARK Invest Sells $4 Million in AMD Shares

36m ago

OpenAI Expands Commercial Operations in India and Brazil

37m ago

Google Pushes Advanced AI Models to Legal Professionals and Students

56m ago